Stock chart
Ticker: FATE Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2022-01-12 2022-01-10 S Sale

Wolchko J Scott

President and CEO

Executive Director
13,161 -2.7%
46.36
610,144 USD
13,161 -2.7% 46.36 610,144 USD
2022-01-12 2022-01-10 S Sale

Valamehr Bahram

Chief R&D Officer

Officer
351 -0.2%
47.17
16,557 USD
351 -0.2% 47.17 16,557 USD
2022-01-12 2022-01-10 S Sale

Valamehr Bahram

Chief R&D Officer

Officer
5,245 -3.3%
46.33
243,001 USD
5,245 -3.3% 46.33 243,001 USD
2022-01-12 2022-01-10 S Sale

TAHL CINDY

General Counsel and Secretary

Officer
643 -0.4%
47.15
30,317 USD
643 -0.4% 47.15 30,317 USD
2022-01-12 2022-01-10 S Sale

TAHL CINDY

General Counsel and Secretary

Officer
7,095 -4.2%
46.37
328,995 USD
7,095 -4.2% 46.37 328,995 USD
2022-01-04 2022-01-03 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
861 -0.5%
60.31
51,927 USD
861 -0.5% 60.31 51,927 USD
2022-01-04 2022-01-03 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
27,812 -14.1%
59.86
1,664,826 USD
27,812 -14.1% 59.86 1,664,826 USD
2022-01-04 2022-01-03 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
16,900 -7.9%
58.84
994,396 USD
16,900 -7.9% 58.84 994,396 USD
2022-01-04 2022-01-03 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
4,427 -2.0%
57.76
255,704 USD
4,427 -2.0% 57.76 255,704 USD
2021-12-21 2021-12-20 PS Planned sale

Dulac Edward J III

Chief Financial Officer

Officer
15,977 -12.6%
60.00
958,620 USD
15,977 -12.6% 60.00 958,620 USD
2021-12-14 2021-12-13 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
1,600 -1.0%
49.27
78,832 USD
1,600 -1.0% 49.27 78,832 USD
2021-12-14 2021-12-13 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
7,718 -4.6%
48.75
376,253 USD
7,718 -4.6% 48.75 376,253 USD
2021-12-14 2021-12-13 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
6,564 -3.8%
47.61
312,512 USD
6,564 -3.8% 47.61 312,512 USD
2021-12-14 2021-12-13 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
7,018 -3.9%
46.72
327,881 USD
7,018 -3.9% 46.72 327,881 USD
2021-12-14 2021-12-13 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
2,100 -1.2%
45.68
95,928 USD
2,100 -1.2% 45.68 95,928 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
5 -0.0%
55.54
278 USD
5 -0.0% 55.54 278 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
600 -0.5%
54.58
32,748 USD
600 -0.5% 54.58 32,748 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,031 -0.8%
53.66
55,323 USD
1,031 -0.8% 53.66 55,323 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,822 -1.4%
52.37
95,418 USD
1,822 -1.4% 52.37 95,418 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,045 -0.8%
51.08
53,379 USD
1,045 -0.8% 51.08 53,379 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
900 -0.7%
50.42
45,378 USD
900 -0.7% 50.42 45,378 USD
2021-12-13 2021-12-10 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
2,097 -1.6%
49.32
103,424 USD
2,097 -1.6% 49.32 103,424 USD
2021-11-22 2021-11-18 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
20,000 -4.8%
54.27
1,085,400 USD
20,000 -4.8% 54.27 1,085,400 USD
2021-10-25 2021-10-22 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -7.1%
58.88
1,766,400 USD
30,000 -7.1% 58.88 1,766,400 USD
2021-10-25 2021-10-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
14,765 -3.6%
60.63
895,202 USD
14,765 -3.6% 60.63 895,202 USD
2021-10-25 2021-10-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
15,235 -3.6%
59.82
911,358 USD
15,235 -3.6% 59.82 911,358 USD
2021-10-04 2021-10-01 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
11,844 -9.9%
59.68
706,862 USD
11,844 -9.9% 59.68 706,862 USD
2021-10-04 2021-10-01 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
21,844 -15.4%
58.96
1,287,966 USD
21,844 -15.4% 58.96 1,287,966 USD
2021-10-04 2021-10-01 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
16,312 -10.3%
58.03
946,634 USD
16,312 -10.3% 58.03 946,634 USD
2021-09-14 2021-09-13 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
800 -0.8%
67.46
53,965 USD
800 -0.8% 67.46 53,965 USD
2021-09-14 2021-09-13 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,391 -8.0%
66.84
560,879 USD
8,391 -8.0% 66.84 560,879 USD
2021-09-14 2021-09-13 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
15,809 -13.1%
65.94
1,042,414 USD
15,809 -13.1% 65.94 1,042,414 USD
2021-08-20 2021-08-19 S Sale

Dulac Edward J III

Chief Financial Officer

Officer
63 -0.1%
90.00
5,670 USD
63 -0.1% 90.00 5,670 USD
2021-08-20 2021-08-19 S Sale

Dulac Edward J III

Chief Financial Officer

Officer
1,474 -2.6%
88.65
130,670 USD
1,474 -2.6% 88.65 130,670 USD
2021-08-20 2021-08-19 S Sale

Dulac Edward J III

Chief Financial Officer

Officer
1,937 -3.3%
87.90
170,262 USD
1,937 -3.3% 87.90 170,262 USD
2021-06-16 2021-06-14 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
400 -0.4%
90.76
36,303 USD
400 -0.4% 90.76 36,303 USD
2021-06-16 2021-06-14 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,220 -7.9%
89.68
737,155 USD
8,220 -7.9% 89.68 737,155 USD
2021-06-16 2021-06-14 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
16,380 -13.6%
89.11
1,459,587 USD
16,380 -13.6% 89.11 1,459,587 USD
2021-04-26 2021-04-23 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -7.1%
85.24
2,557,284 USD
30,000 -7.1% 85.24 2,557,284 USD
2021-04-26 2021-04-22 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -7.1%
85.54
2,566,212 USD
30,000 -7.1% 85.54 2,566,212 USD
2021-04-20 2021-04-16 S Sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,500 -2.3%
84.41
126,615 USD
1,500 -2.3% 84.41 126,615 USD
2021-04-20 2021-04-16 S Sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
900 -1.3%
82.91
74,619 USD
900 -1.3% 82.91 74,619 USD
2021-04-20 2021-04-16 S Sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
875 -1.3%
81.80
71,575 USD
875 -1.3% 81.80 71,575 USD
2021-03-16 2021-03-15 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
1,018 -1.1%
94.59
96,297 USD
1,018 -1.1% 94.59 96,297 USD
2021-03-16 2021-03-15 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
3,205 -3.2%
93.75
300,461 USD
3,205 -3.2% 93.75 300,461 USD
2021-03-16 2021-03-15 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,404 -7.8%
92.64
778,578 USD
8,404 -7.8% 92.64 778,578 USD
2021-03-16 2021-03-15 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,416 -7.2%
91.94
773,782 USD
8,416 -7.2% 91.94 773,782 USD
2021-03-16 2021-03-15 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
3,957 -3.3%
90.89
359,654 USD
3,957 -3.3% 90.89 359,654 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
800 -1.1%
86.70
69,360 USD
800 -1.1% 86.70 69,360 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,900 -3.8%
85.50
247,956 USD
2,900 -3.8% 85.50 247,956 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,728 -3.4%
84.20
229,705 USD
2,728 -3.4% 84.20 229,705 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,480 -3.0%
83.46
206,989 USD
2,480 -3.0% 83.46 206,989 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,993 -3.5%
81.60
244,224 USD
2,993 -3.5% 81.60 244,224 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
5,174 -5.7%
80.73
417,722 USD
5,174 -5.7% 80.73 417,722 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
4,627 -4.9%
79.58
368,236 USD
4,627 -4.9% 79.58 368,236 USD
2021-03-09 2021-03-08 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
3,298 -3.4%
78.60
259,236 USD
3,298 -3.4% 78.60 259,236 USD
2021-02-19 2021-02-18 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
5,547 -1.4%
103.16
572,206 USD
5,547 -1.4% 103.16 572,206 USD
2021-02-19 2021-02-18 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
8,602 -2.1%
102.26
879,661 USD
8,602 -2.1% 102.26 879,661 USD
2021-02-19 2021-02-18 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
2,602 -0.6%
101.42
263,883 USD
2,602 -0.6% 101.42 263,883 USD
2021-02-19 2021-02-18 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
1,848 -0.4%
100.48
185,691 USD
1,848 -0.4% 100.48 185,691 USD
2021-02-19 2021-02-18 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
1,401 -0.3%
99.08
138,817 USD
1,401 -0.3% 99.08 138,817 USD
2021-01-22 2021-01-22 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
3,075 -0.8%
100.01
307,545 USD
3,075 -0.8% 100.01 307,545 USD
2021-01-22 2021-01-22 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
6,520 -1.6%
99.35
647,732 USD
6,520 -1.6% 99.35 647,732 USD
2021-01-22 2021-01-22 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
7,638 -1.9%
98.45
751,952 USD
7,638 -1.9% 98.45 751,952 USD
2021-01-22 2021-01-22 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
12,767 -3.0%
97.23
1,241,383 USD
12,767 -3.0% 97.23 1,241,383 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
200 -0.1%
106.96
21,391 USD
200 -0.1% 106.96 21,391 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
645 -0.2%
106.03
68,392 USD
645 -0.2% 106.03 68,392 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
4,271 -1.1%
105.25
449,517 USD
4,271 -1.1% 105.25 449,517 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
9,156 -2.2%
104.13
953,438 USD
9,156 -2.2% 104.13 953,438 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
3,895 -0.9%
103.23
402,086 USD
3,895 -0.9% 103.23 402,086 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
3,300 -0.8%
101.91
336,314 USD
3,300 -0.8% 101.91 336,314 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
5,993 -1.4%
101.09
605,808 USD
5,993 -1.4% 101.09 605,808 USD
2021-01-22 2021-01-21 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
2,540 -0.6%
100.16
254,411 USD
2,540 -0.6% 100.16 254,411 USD
2021-01-21 2021-01-19 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
200 -0.2%
117.07
23,413 USD
200 -0.2% 117.07 23,413 USD
2021-01-21 2021-01-19 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
4,021 -4.3%
115.97
466,333 USD
4,021 -4.3% 115.97 466,333 USD